Antonio Dans

3.4k total citations · 2 hit papers
13 papers, 1.4k citations indexed

About

Antonio Dans is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Antonio Dans has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Economics and Econometrics and 3 papers in Molecular Biology. Recurrent topics in Antonio Dans's work include Blood Pressure and Hypertension Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and ECG Monitoring and Analysis (2 papers). Antonio Dans is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and ECG Monitoring and Analysis (2 papers). Antonio Dans collaborates with scholars based in Philippines, Canada and United States. Antonio Dans's co-authors include Salim Yusuf, Janice Pogue, Prem Pais, Jonas Oldgren, Marco Alings, Stuart J. Connolly, Michael D. Ezekowitz, Sean Yang, Lars Wallentin and Maria Grazia Franzosi and has published in prestigious journals such as The Lancet, JAMA and Diabetes Care.

In The Last Decade

Antonio Dans

12 papers receiving 1.4k citations

Hit Papers

Efficacy and safety of dabigatran compared with warfarin ... 2010 2026 2015 2020 2010 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
    2010 728 citations Lars Wallentin, Salim Yusuf et al. The Lancet profile →
  2. Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events
    2011 425 citations Martin O’Donnell, Salim Yusuf et al. JAMA profile →

Peers

Antonio Dans
Giovanni B. Ambrosio Italy
Jiang He United States
Ji Guang Wang China
Aud Høieggen Norway
John Coope United Kingdom
Miguel Camafort Spain
Chang‐Sheng Sheng China
L Vaur France
Melvin J. Schwartz United States
Mary R. Rooney United States
Giovanni B. Ambrosio Italy
Antonio Dans
Citations per year, relative to Antonio Dans Antonio Dans (= 1×) peers Giovanni B. Ambrosio

Countries citing papers authored by Antonio Dans

Since Specialization
Citations

This map shows the geographic impact of Antonio Dans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Dans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Dans more than expected).

Fields of papers citing papers by Antonio Dans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Dans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Dans. The network helps show where Antonio Dans may publish in the future.

Co-authorship network of co-authors of Antonio Dans

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Dans. A scholar is included among the top collaborators of Antonio Dans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Dans. Antonio Dans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Seguin, Maureen, Gideon Lasco, Khairuddin Idris, et al.. (2021). Patient pathways for cardiovascular diseases in Malaysia and the Philippines: a systematic review. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 6. 43–43. 3 indexed citations
4.
Loeb, Mark, Hisham Dokainish, Antonio Dans, et al.. (2019). Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design. American Heart Journal. 212. 36–44. 33 indexed citations
5.
Pais, Prem, Hye Jung Jung, Antonio Dans, et al.. (2018). Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study. European Journal of Preventive Cardiology. 26(7). 681–697. 6 indexed citations
6.
Teo, Koon, Marc A. Pfeffer, Giuseppe Mancia, et al.. (2014). Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. European Heart Journal. 35(26). 1743–1751. 23 indexed citations
7.
O’Donnell, Martin, Salim Yusuf, Andrew Mente, et al.. (2011). Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events. JAMA. 306(20). 2229–38. 425 indexed citations breakdown →
8.
Barzilay, Joshua I., Peggy Gao, Lars Rydén, et al.. (2011). Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes. Diabetes Care. 34(9). 1902–1907. 25 indexed citations
9.
Lamy, André, Xiaoyin Wang, Peggy Gao, et al.. (2011). The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. Journal of Medical Economics. 14(6). 792–797. 6 indexed citations
10.
Dans, Antonio, et al.. (2010). Frequency of Cardiac Events at Four Years Among Initially Asymptomatic Filipinos with the Brugada Type 1 Electrocardiographic Pattern. The American Journal of Cardiology. 107(5). 714–716. 4 indexed citations
11.
Wallentin, Lars, Salim Yusuf, Michael D. Ezekowitz, et al.. (2010). Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. The Lancet. 376(9745). 975–983. 728 indexed citations breakdown →
12.
Anderson, Craig S., Koon Teo, Peggy Gao, et al.. (2010). Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. The Lancet Neurology. 10(1). 43–53. 149 indexed citations
13.
Morales, Dante D., et al.. (2008). The Brugada type 1 electrocardiographic pattern is common among Filipinos. Journal of Clinical Epidemiology. 61(10). 1067–1072. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni B. Ambrosio Breakdown of academic impact, for papers by Jiang He Breakdown of academic impact, for papers by Ji Guang Wang Breakdown of academic impact, for papers by Aud Høieggen Breakdown of academic impact, for papers by John Coope Breakdown of academic impact, for papers by Miguel Camafort Breakdown of academic impact, for papers by Chang‐Sheng Sheng Breakdown of academic impact, for papers by L Vaur Breakdown of academic impact, for papers by Melvin J. Schwartz Breakdown of academic impact, for papers by Mary R. Rooney
Rankless by CCL
2026